新癀片预防肝动脉栓塞化疗术后发热临床观察

Clinical observation of "Xinhuang Tablet" in preventing fever after transcatheter arterial chemoembolization

目的观察新癀片预防肝动脉栓塞化疗术(TACE)后发热的临床疗效。方法将49例病例随机分为观察组27例和对照组22例。两组均在TACE术后予常规对症处理,观察组同时口服新癀片,连续7天;观察患者发热程度和发热时间。结果观察组发热发生率为25.93%,明显低于对照组的86.36%(P<0.01);观察组发热程度较对照组轻(P<0.05),平均发热持续时间较对照组缩短(P<0.05)。结论新癀片能有效预防TACE术后发热的发生。

Objective To observe the therapeutic effects of ＂Xinhuang Tablet＂ in preventing fever after transcatheter arterial chemoembolization.Methods The observation group with 27 cases was treated orally with ＂Xinhuang Tablet＂ on the day of TACE for 7 days;while the control group with 22 cases were treated by pyretolysis management.Results The incidence rate of fever in the observation group was 25.93%,lower than 86.36% in the control group（P0.01）;the degree of fever and the average duration of fever were shorter in the observation group than in the control group（P0.05）.Conclusion ＂Xinhuang Tablet＂ is effective to prevent fever after transcatheter arterial chemoembolization.